APA (7th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. (2018). Pharmacoeconomic review report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) (Purdue pharma). CADTH.

Chicago Style (17th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Netupitant/Palonosetron 300 Mg/0.5 Mg (Akynzeo) (Purdue Pharma). Ottawa (ON): CADTH, 2018.

MLA (9th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Netupitant/Palonosetron 300 Mg/0.5 Mg (Akynzeo) (Purdue Pharma). CADTH, 2018.